1921
Volume 99, Issue 3_Suppl
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Typhoid fever, caused by serovar Typhi (. Typhi), is a diminishing public health problem in Vietnam, and this process may represent a prototype for typhoid elimination in Asia. Here, we review typhoid epidemiology in Vietnam over 20 years and assess the potential drivers associated with typhoid reduction. In the 1990s, multidrug resistant . Typhi were highly prevalent in a sentinel hospital in southern Vietnam. A national typhoid incidence rate of 14.7/100,000 population per year was estimated around the new millennium. The Vietnamese government recognized the public health issue of typhoid in the 1990s and initiated vaccine campaigns to protect the most vulnerable members of the population. At their peak, these campaigns immunized approximately 1,200,000 children in 35 provinces. Concurrently, Vietnam experienced unprecedented economic development from 1998 to 2014, with the gross national income per capita increasing from $360 to $1,890 over this period. More recent typhoid incidence data are not available, but surveillance suggests that the current disease burden is negligible. This trajectory can be considered a major public health success. However, a paucity of systematic data makes it difficult to disaggregate the roles of immunization and water, sanitation, and hygiene (WASH) interventions in typhoid reduction in Vietnam. Given the limitations of typhoid vaccines, we surmise the practical elimination of typhoid was largely driven by economic development and improvement in general population living standards. Better designed WASH intervention studies with clinical endpoints and systematic incidence data are essential to glean a greater understanding of contextual factors that impact typhoid incidence reduction.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.18-0035
2018-07-25
2019-11-20
Loading full text...

Full text loading...

/deliver/fulltext/14761645/99/3_Suppl/tpmd180035.html?itemId=/content/journals/10.4269/ajtmh.18-0035&mimeType=html&fmt=ahah

References

  1. Nga TVT, 2012. The decline of typhoid and the rise of non-typhoid salmonellae and fungal infections in a changing HIV landscape: bloodstream infection trends over 15 years in southern Vietnam. Trans R Soc Trop Med Hyg 106: 2634. [Google Scholar]
  2. Pham Thanh D, 2016. The molecular and spatial epidemiology of typhoid fever in rural Cambodia. PLoS Negl Trop Dis 10: e0004785. [Google Scholar]
  3. Baker S, 2011. Combined high-resolution genotyping and geospatial analysis reveals modes of endemic urban typhoid fever transmission. Open Biol 1: 110008. [Google Scholar]
  4. Hendriksen RS, 2015. Genomic dissection of travel-associated extended-spectrum-beta-lactamase-producing Salmonella enterica serovar typhi isolates originating from the Philippines: a one-off occurrence or a threat to effective treatment of typhoid fever? J Clin Microbiol 53: 677680. [Google Scholar]
  5. Baker S, Hombach J, Marks F, , 2016. What have we learned from the typhoid fever surveillance in Africa program? Clin Infect Dis 62 (Suppl 1): S1S3. [Google Scholar]
  6. World Health Organization, 1968. Epidemiological Situation in Viet-Nam. Twenty-first World Health Assembly Agenda, May 6–24, 1968, Geneva, Switzerland.
  7. Greenberg JH, , 1969. Public health problems relating to the Vietnam returnee. JAMA 207: 697702. [Google Scholar]
  8. Levy BS, Sidel V, , 2008. War and Public Health, 1st edition. New York, NY: Oxford University Press.
  9. Ochiai RL, Domi Typhoid Study Group , 2008. A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ 86: 260268. [Google Scholar]
  10. Ali M, Thiem VD, Park JK, Ochiai RL, Canh DG, Danovaro-Holliday MC, Kaljee LM, Clemens JD, Acosta CJ, , 2007. Geographic analysis of vaccine uptake in a cluster-randomized controlled trial in Hue, Vietnam. Health Place 13: 577587. [Google Scholar]
  11. Cook J, Jeuland M, Whittington D, Poulos C, Clemens J, Sur D, Anh DD, Agtini M, Bhutta Z, DOMI Typhoid Economics Study Group; , 2008. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries. Vaccine 26: 63056316. [Google Scholar]
  12. Cuong N, , 2011. Typhoid Vaccine Used in Vietnam and its Impact. Consultation on Typhoid Vaccine Introduction and Typhoid Surveillance. Available at: https://www.sabin.org/sites/sabin.org/files/CUONG%20Typhoid%20Vaccine%20in%20Vietnam.pdf. Accessed June 10, 2018.
  13. Lin FY, Vo AH, Phan VB, Nguyen TT, Bryla D, Tran CT, Ha BK, Dang DT, Robbins JB, , 2000. The epidemiology of typhoid fever in the Dong Thap Province, Mekong Delta region of Vietnam. Am J Trop Med Hyg 62: 644648. [Google Scholar]
  14. Gordon MA, Banda HT, Gondwe M, Gordon SB, Boeree MJ, Walsh AL, Corkill JE, Hart CA, Gilks CF, Molyneux ME, , 2002. Non-typhoidal Salmonella bacteraemia among HIV- infected Malawian adults: high mortality and frequent recrudescence. AIDS 16: 16331641. [Google Scholar]
  15. Le T, 2011. Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam. Clin Infect Dis 52: 945952. [Google Scholar]
  16. Phu Huong Lan N, 2016. Invasive non-typhoidal Salmonella infections in Asia: clinical observations, disease outcome and dominant serovars from an infectious disease hospital in Vietnam. PLoS Negl Trop Dis 10: e0004857. [Google Scholar]
  17. Ochiai RL, 2005. Salmonella paratyphi A rates, Asia. Emerg Infect Dis 11: 17641766. [Google Scholar]
  18. Vlieghe E, Phe T, De Smet B, Veng CH, Kham C, Sar D, van Griensven J, Lim K, Thai S, Jacobs J, , 2013. Increase in Salmonella enterica serovar Paratyphi A infections in Phnom Penh, Cambodia, January 2011 to August 2013. Euro Surveill 18: pii: 20592. [Google Scholar]
  19. Global Burden of Disease, 2018. Global Burden of Disease Results Tool. GBD Results Tool | GHDx. Available at: http://ghdx.healthdata.org/gbd-results-tool. Accessed May 1, 2018.
  20. Chinh NT, Parry CM, Ly NT, Ha HD, Thong MX, Diep TS, Wain J, White NJ, Farrar JJ, , 2000. A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrob Agents Chemother 44: 18551859. [Google Scholar]
  21. Hoa NT, Diep TS, Wain J, Parry CM, Hien TT, Smith MD, Walsh AL, White NJ, , 1998. Community-acquired septicaemia in southern Viet Nam: the importance of multidrug-resistant Salmonella typhi. Trans R Soc Trop Med Hyg 92: 503508. [Google Scholar]
  22. Wain J, 2003. Molecular analysis of incHI1 antimicrobial resistance plasmids from Salmonella serovar Typhi strains associated with typhoid fever. Antimicrob Agents Chemother 47: 27322739. [Google Scholar]
  23. Holt KE, 2011. Emergence of a globally dominant IncHI1 plasmid type associated with multiple drug resistant typhoid. PLoS Negl Trop Dis 5: e1245. [Google Scholar]
  24. Wong VK, International Typhoid Consortium , 2016. An extended genotyping framework for Salmonella enterica serovar Typhi, the cause of human typhoid. Nat Commun 7: 12827. [Google Scholar]
  25. Holt KE, 2011. Temporal fluctuation of multidrug resistant Salmonella typhi haplotypes in the Mekong River Delta region of Vietnam. PLoS Negl Trop Dis 5: e929. [Google Scholar]
  26. Parry CM, Vinh H, Chinh NT, Wain J, Campbell JI, Hien TT, Farrar JJ, Baker S, , 2011. The influence of reduced susceptibility to fluoroquinolones in Salmonella enterica serovar Typhi on the clinical response to ofloxacin therapy. PLoS Negl Trop Dis 5: e1163. [Google Scholar]
  27. Wong VK, 2015. Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella typhi identifies inter- and intracontinental transmission events. Nat Genet 47: 632639. [Google Scholar]
  28. Wain J, 1997. Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis 25: 14041410. [Google Scholar]
  29. Connerton P, 2000. Epidemic typhoid in Vietnam: molecular typing of multiple-antibiotic-resistant Salmonella enterica serotype typhi from four outbreaks. J Clin Microbiol 38: 895897. [Google Scholar]
  30. Pham Thanh D, 2016. A novel ciprofloxacin-resistant subclade of H58 Salmonella typhi is associated with fluoroquinolone treatment failure. ELife 5: e14003. [Google Scholar]
  31. DeRoeck D, Ochiai RL, Yang J, Anh DD, Alag V, Clemens JD, , 2008. Typhoid vaccination: the Asian experience. Expert Rev Vaccines 7: 547560. [Google Scholar]
  32. Tran TH, 2010. A randomised trial evaluating the safety and immunogenicity of the novel single oral dose typhoid vaccine M01ZH09 in healthy Vietnamese children. PLoS One 5: e11778. [Google Scholar]
  33. Lin FY, 2001. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med 344: 12631269. [Google Scholar]
  34. Karkey A, 2013. Differential epidemiology of Salmonella Typhi and Paratyphi A in Kathmandu, Nepal: a matched case control investigation in a highly endemic enteric fever setting. PLoS Negl Trop Dis 7: e2391. [Google Scholar]
  35. Vandemoortele M, Bird K, Steer L, , 2011. Viet Nam’s Progress on Economic Growth and Poverty Reduction: Impressive Improvements. London. Available at: http://www.developmentprogress.org/sites/developmentprogress.org/files/viet_nam_report_-_master_0.pdf. Accessed June 10, 2018.
  36. IndexMundi, 2016. Facts About Vietnam. Available at: http://www.indexmundi.com/facts/vietnam. Accessed January 13, 2017.
  37. Karkey A, 2016. The ecological dynamics of fecal contamination and Salmonella Typhi and Salmonella Paratyphi a in municipal Kathmandu drinking water. PLoS Negl Trop Dis 10: e0004346. [Google Scholar]
  38. UNICEF, 2015. Multiple Indicator Cluster Survey (MICS). Statistics and Monitoring. Available at: https://www.unicef.org/statistics/index_countrystats.html. Accessed January 13, 2017.
  39. The World Bank, 2016. World Bank Open Data—Vietnam. Available at: http://data.worldbank.org/country/vietnam. Accessed January 13, 2017.
  40. Nguyen QC, 2004. A clinical, microbiological, and pathological study of intestinal perforation associated with typhoid fever. Clin Infect Dis 39: 6167. [Google Scholar]
  41. Parry CM, Thompson C, Vinh H, Chinh NT, Phuong le T, Ho VA, Hien TT, Wain J, Farrar JJ, Baker S, , 2014. Risk factors for the development of severe typhoid fever in Vietnam. BMC Infect Dis 14: 73. [Google Scholar]
  42. Khan MI, Soofi SB, Ochiai RL, Habib MA, Sahito SM, Nizami SQ, Acosta CJ, Clemens JD, Bhutta ZA, DOMI Typhoid Karachi Vi Effectiveness Study Group; , 2012. Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan. Vaccine 30: 53895395. [Google Scholar]
  43. Sur D, 2009. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India. N Engl J Med 361: 335344. [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.18-0035
Loading
/content/journals/10.4269/ajtmh.18-0035
Loading

Data & Media loading...

  • Received : 15 Jan 2018
  • Accepted : 05 May 2018
  • Published online : 25 Jul 2018

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error